RTI International, parent company of RTI Health Solutions, has been named among Forbes’ Best Employers for Women.
Updates
Top-scorers demonstrated commitment to disability inclusion and equality RTI International, a nonprofit research institute and parent company of RTI Health Solutions, has
Despite recent advances in the treatment of psoriatic arthritis (PsA), for some who live with the condition, available treatments do not supply adequate relief for their most troublesome symptoms. To help improve lives, new treatments need to address these unmet needs.
Learn more about the award-winning presentation along with our full list of RTI-HS contributions to ISPOR 2022.
One of the cultural pillars at RTI Health Solutions (RTI-HS) is respect for the individual. Throughout the organization, colleagues work to show respect toward others and hold themselves accountable to this principle.
Bradley, who has been a member of ISPE since 2011, was recommended for this honor by a committee of his peers
Andrea Margulis, MD, ScD, FISPE, Epidemiology Director at RTI Health Solutions, elected to the International Society for Pharmacoepidemiology (ISPE) Board of Directors.
The recognition honors companies demonstrating exceptional leadership and a commitment to business integrity through best-in-class ethics, compliance, and governance practices
Guidance Expanded to Reflect Developments in Reporting Economic Evaluations of Health Interventions
Most of what we know about treatments, adverse events, and the overall survival of patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) comes from clinical trials. However, confirmatory real-world evidence, especially in the Medicare population, is limited.
Kenneth J. Rothman, DrPH, formerly Vice President of Epidemiology Research at RTI Health Solutions, has transitioned to Distinguished Fellow Emeritus after 16 years with RTI-Health Solutions.
RTI-HS is collaborating with the FDA to ensure that rigorous, valid methods are used to evaluate COVID-19 vaccine effectiveness in the real world.
The institute also earned a high ranking on the Military Friendly® Supplier Diversity Program list
The ways COVID-19 vaccines are being administered have changed substantially in the last few months. Issues such as mixing and matching vaccines, boosters, and vaccine use in children are fundamentally changing that landscape.
Gaining optimal vaccination coverage for older adults in the US
When a person donates blood platelets, those platelets become life-saving treatments for a variety of conditions.
The ENCePP Guide on Methodological Standards in Pharmacoepidemiology was created and is maintained by members of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)–specifically, the ENCePP Working Group 1 on Research Methods and Guidance, chaired by RTI Health
At the forefront of this cause are groups dedicated to keeping patients and the people who care for them at the center of the conversation.
Major depressive disorder (MDD) is a leading cause of disability worldwide. Understanding the impact of MDD on quality of life has become increasingly key in research.
Understanding genetic testing results is complicated, so national guidelines recommend genetic counseling for those considering or undergoing testing. In a recent study, investigators assessed how genetic counseling is utilized in patient care.
Adult vaccination rates in the US are generally low and fall short of public health goals. Given the human and economic burden of vaccine-preventable disease, understanding the factors behind these low coverage rates is critical to improving participation.
There are 3 on-demand treatment therapies to relieve PD off-episodes. Researchers conducted a patient-preference study to understand which aspects of the treatments patients value most.
What do rapidly changing technologies mean to the collection of stated-preference studies – studies that ask individuals what they value in their health and health care?
Insights from our experiences developing medical product dossiers with key considerations for manufacturers planning to develop early dossiers for their products.
EMA has recently launched the MINERVA project aimed at strengthening the use of real-world data in medicines development. RTI Health Solutions researchers will coordinate the project.